The European interventional oncology device market will be characterized by procedure volume growth, spurred by enhanced reimbursement, product improvements, and the availability of new technologies.

This Medtech 360 Report provides high-level market metrics for devices used in interventional oncology in Europe, including country-level data for major countries and aggregate data for the rest of Europe, across a 10-year period.

Table of contents

  • Europe (Supplemental)
    • Abstract
    • Version History
    • Key Report Updates
    • Interventional Oncology Device Market
      • Market Definitions
        • Geographies Covered
        • Procedures Covered
        • Products Covered
      • Market Forecast Data
    • Ablation Device Market
      • Market Definitions
      • Market Forecast Data
    • Embolization Particle Market
      • Market Definitions
      • Market Forecast Data
    • Appendix
      • Abbreviations

Author(s): Bishwjit Ghoshal, MBA

Bishwjit Ghoshal is an analyst within the Cardiovascular Medtech Insights team at Decision Resources Group, specializing in interventional oncology and vascular access device markets. Bishwjit holds a Bachelor's degree in Pharmacy from the University of Delhi and an MBA in Pharmaceutical Marketing from the National Institute of Pharmaceutical Education and Research, Mohali.


Related Reports

Interventional Oncology Devices | Medtech 360 | Market Insights | Asia Pacific

Despite pricing pressures and the release of mixed clinical data, the Asia Pacific interventional oncology device market will expand rapidly through 2027, driven by the continued growth of cance...

View Details

Interventional Oncology Devices | Medtech 360 | Market Insights | Europe

The European interventional oncology device market will be driven by moderate procedure volume growth, spurred by enhanced cancer detection, rising patient and physician awareness, improved reim...

View Details

Interventional Oncology Devices | Medtech 360 | Market Insights | Asia Pacific (Supplemental)

The Asia Pacific market for interventional oncology will expand through 2027, driven primarily by continued growth of cancer incidence, improving access to treat...

View Details

Interventional Oncology Devices | Medtech 360 | Market Insights | United States

The US market for interventional oncology devices continues to grow, driven by expanding treatable patient populations and increasing uptake of premium-priced technology. However, growth in...

View Details